Gargi D Roy

age ~48

from Shrewsbury, MA

Get Report

Also known as:

Gargi D Duttaroy
Gargi Sinha
Gargi Dutta-Roy
Gargi Dutta
Roy Gargi Dutta
Roy D Gargi

Phone and address:: 16 Birch Brush Rd, Shrewsbury, MA 01545

Connected to:

Gargi Roy Phones & Addresses

16 Birch Brush Rd, Shrewsbury, MA 01545
Marlborough, MA
Manchester, CT

Work

Company:

Avidia bank
Feb 2019
Position:

Branch manager

Education

Degree:

Bachelors, Bachelor of Arts
School / High School:

Calcutta University, Kolkata
1997 to 1999
Specialities:

Marketing, Advertising

Skills

Banking • Deposits • Risk Management • Commercial Banking • Credit Analysis • Crm • Commercial Lending • Financial Analysis • Marketing • Mortgage Lending • Microsoft Excel • Credit Risk • Financial Risk • Microsoft Word • Cash Management • Outlook • Time Management • Data Entry • Telephone Skills • Underwriting • Customer Retention • Powerpoint • Aml

Industries

Banking

Us Patents

Proteoglycan Degrading Mutants For The Treatment Of Cns
view source
US Patent:

7968089, Jun 28, 2011
Filed:

Jul 3, 2008
Appl. No.:

12/167573
Inventors:

Elliott A. Gruskin - Killingworth CT, US
Anthony O. Caggiano - Larchmont NY, US
Gargi Roy - Danbury CT, US
Rohini D'Souza - Croton on Hudson NY, US
Assignee:

Acorda Therapeutics, Inc. - Hawthorne NY
International Classification:

A61K 38/51
C12N 15/60
C12N 9/88
US Classification:

424 945, 435232, 536 232
Abstract:

The present disclosure relates to the preparation and deletion mutants of chondroitinase proteins and their use in methods for promoting the diffusion of therapeutic composition into tissues and their use for neurological functional recovery after central nervous system (“CNS”) injury or disease.

Compositions And Methods For Promoting Neuronal Outgrowth
view source
US Patent:

8183350, May 22, 2012
Filed:

May 5, 2003
Appl. No.:

10/513573
Inventors:

Elliott A. Gruskin - Killingworth CT, US
Jennifer F. Iaci - Boonton NJ, US
Andrea M. Vecchione - Mount Vernon NY, US
Sarah J. Kasperbauer - Cortlandt NY, US
Gargi Roy - Boyds MD, US
Assignee:

Acorda Therapeutics, Inc. - Hawthorne NY
International Classification:

A61K 38/48
A61K 31/726
A61K 31/737
US Classification:

530395, 514 165, 514 177, 424 946
Abstract:

Neural outgrowth in the central nervous system is achieved by administering chondroitinase AC and/or chondroitinase B to degrade chondroitin sulfate proteoglycans that inhibit or contribute to the inhibition of nervous tissue regeneration.

Proteoglycan Degrading Mutants For The Treatment Of Cns
view source
US Patent:

20060233782, Oct 19, 2006
Filed:

May 17, 2004
Appl. No.:

10/848561
Inventors:

Elliott Gruskin - Killingworth CT, US
Rohini D'Souza - Croton on Hudson NY, US
Gargi Roy - Danbury CT, US
Anthony Caggiano - Larchmont NY, US
International Classification:

A61K 38/47
A61K 35/30
C07H 21/04
C12P 21/06
C12N 9/24
C12N 15/06
US Classification:

424094610, 536023200, 435200000, 435325000, 435320100, 435069100
Abstract:

The present disclosure relates to the preparation and deletion mutants of chondroitinase proteins and their use in methods for promoting the diffusion of therapeutic composition into tissues and their use for neurological functional recovery after central nervous system (“CNS”) injury or disease.

Fusion Proteins For The Treatment Of Cns
view source
US Patent:

20090028829, Jan 29, 2009
Filed:

May 17, 2004
Appl. No.:

10/848564
Inventors:

Elliott A. Gruskin - Killingworth CT, US
Anthony O. Caggiano - Larchmont NY, US
Gargi Roy - Danbury CT, US
Jennifer Iaci - Montville NJ, US
Michael P. Zimber - Mamroneck NY, US
International Classification:

A61K 35/12
A61K 38/47
A61K 38/02
A61P 25/00
US Classification:

424 937, 424 9461, 424 9462
Abstract:

This disclosure relates to compositions capable of use in the treatment of spinal cord injuries and related disorders of the central nervous system (CNS), and in particular, compositions including proteoglycan degrading molecules and compositions capable of blocking and/or over coming the activity of neuronal growth inhibitory molecules, as well as fusion proteins which includes a proteoglycan degrading domain and a domain capable of blocking and or over coming the activity of neuronal growth inhibitory molecules.

Proteoglycan Degrading Mutants For Treatment Of Cns
view source
US Patent:

20110250631, Oct 13, 2011
Filed:

May 20, 2011
Appl. No.:

13/112985
Inventors:

Elliott A. GRUSKIN - Killingworth CT, US
Rohini D'SOUZA - Croton on Hudson NY, US
Gargi ROY - Danbury CT, US
Anthony G. Caggiano - Larchmont NY, US
International Classification:

C12Q 1/02
C12N 9/26
C12N 5/071
C12N 9/24
C07H 21/00
C12N 15/63
US Classification:

435 29, 536 232, 4353201, 435325, 435200, 435201
Abstract:

The present disclosure relates to the preparation and deletion mutants of chondroitinase proteins and their use in methods for promoting the diffusion of therapeutic composition into tissues and their use for neurological functional recovery after central nervous system (“CNS”) injury or disease.

Resumes

Branch Manager

view source

Location:

Shrewsbury, MA

Industry:

Banking

Work:

Avidia Bank
Branch Manager
Avidia Bank
Branch Relationship Officer
Avidia Bank May 1, 2012 - Jan 2018
Assistant Branch Manager
Avidia Bank Oct 2007 - May 2013
Customer Service Representative
Continental Advertising Services Contad Apr 1999 - Oct 2000
Client Servicing

Education:

Calcutta University, Kolkata 1997 - 1999
Bachelors, Bachelor of Arts, Marketing, Advertising Calcutta University, Kolkata 1984 - 1994
Gokhlale Memorial Girls' School

Skills:

Banking
Deposits
Risk Management
Commercial Banking
Credit Analysis
Crm
Commercial Lending
Financial Analysis
Marketing
Mortgage Lending
Microsoft Excel
Credit Risk
Financial Risk
Microsoft Word
Cash Management
Outlook
Time Management
Data Entry
Telephone Skills
Underwriting
Customer Retention
Powerpoint
Aml